Balentine LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,103
Closed -$4.22M 571
2024
Q1
$4.22M Sell
10,103
-81
-0.8% -$33.9K 0.13% 56
2023
Q4
$4.14M Buy
10,184
+463
+5% +$188K 0.13% 60
2023
Q3
$3.38M Buy
9,721
+11
+0.1% +$3.83K 0.11% 62
2023
Q2
$3.42M Buy
9,710
+689
+8% +$242K 0.11% 63
2023
Q1
$2.84M Sell
9,021
-149
-2% -$46.9K 0.1% 73
2022
Q4
$2.65M Buy
9,170
+464
+5% +$134K 0.09% 79
2022
Q3
$2.52M Sell
8,706
-2,154
-20% -$624K 0.1% 64
2022
Q2
$3.06M Buy
10,860
+8,357
+334% +$2.35M 0.11% 71
2022
Q1
$653K Buy
+2,503
New +$653K 0.02% 247
2020
Q4
Sell
-952
Closed -$259K 188
2020
Q3
$259K Sell
952
-19
-2% -$5.17K 0.01% 104
2020
Q2
$282K Buy
971
+49
+5% +$14.2K 0.02% 71
2020
Q1
$219K Buy
922
+341
+59% +$81K 0.01% 60
2019
Q4
$127K Buy
581
+285
+96% +$62.3K 0.01% 101
2019
Q3
$50K Hold
296
﹤0.01% 134
2019
Q2
$54K Buy
296
+35
+13% +$6.39K ﹤0.01% 103
2019
Q1
$48K Hold
261
﹤0.01% 124
2018
Q4
$43K Hold
261
﹤0.01% 122
2018
Q3
$50K Buy
+261
New +$50K ﹤0.01% 70
2018
Q1
Sell
-649
Closed -$97K 508
2017
Q4
$97K Hold
649
0.01% 196
2017
Q3
$99K Sell
649
-197
-23% -$30.1K 0.01% 189
2017
Q2
$109K Sell
846
-24
-3% -$3.09K 0.01% 158
2017
Q1
$95K Hold
870
0.01% 171
2016
Q4
$64K Buy
870
+235
+37% +$17.3K 0.01% 188
2016
Q3
$55K Buy
635
+506
+392% +$43.8K 0.01% 162
2016
Q2
$11K Buy
+129
New +$11K ﹤0.01% 334
2015
Q4
Sell
-503
Closed -$52K 476
2015
Q3
$52K Sell
503
-73
-13% -$7.55K 0.01% 166
2015
Q2
$71K Buy
576
+73
+15% +$9K 0.01% 123
2015
Q1
$59K Buy
+503
New +$59K 0.01% 125